Wenli Diao

机构：Nanjing University of Chinese Medicine, Nanjing Drum Tower Hospital, Nanjing University

发表论文 51 篇 · 总被引 934 次 · h-index 18

代表论文

Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis (2022 · Journal of Hematology & Oncology · 被引 51)
ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy (2023 · Advanced Healthcare Materials · 被引 48)
Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation (2022 · Nature Communications · 被引 46)
Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer (2024 · Molecular Cancer · 被引 45)
Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p (2022 · Cell Death Discovery · 被引 36)
MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma (2023 · Redox Biology · 被引 26)